Completed

Efficacy and Safety of Hizikia Fusiformis Extract in Subjects Showing Erosive Gastritis

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Hizikia Fusiformis extract

+ Placebo

Dietary Supplement
Who is being recruted

From 19 to 70 Years
+10 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Placebo-Controlled
Interventional
Study Start: August 2011
See protocol details

Summary

Principal SponsorChonbuk National University Hospital
Last updated: September 20, 2019
Sourced from a government-validated database.Claim as a partner

Study start date: August 1, 2011

Actual date on which the first participant was enrolled.

The investigators performed a double-blind parallel study in a group of Subjects Showing Erosive Gastritis who were given Hizikia Fusiformis Extract over a period of 4 weeks. Endoscopic observations were performed before and 4 weeks after the treatment, and the cure and improvement rates were investigated.

NCT01689701
Principal SponsorChonbuk National University Hospital
Last updated: September 20, 2019
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

54 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 19 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

3 inclusion criteria required to participate
Able to give informed consent
Males and females 19-70 years old
Subjects Showing Erosive Gastritis (endoscopy)
7 exclusion criteria prevent from participating
Allergic or hypersensitive to any of the ingredients in the test products
Diagnosed of gastrointestinal disease such as ulcer, cancer within 1 months
History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease or gastrointestinal surgery
Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental

Group II

Placebo

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers